|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Nat Med:靶向两分子或有助于彻底治愈白血病显示文摘科学家在癌细胞内发现两个信号蛋白能够让癌细胞抵抗化疗。研究表明阻断这两种蛋白能够增强化疗对人类白血病小鼠模型的治疗效果。相关研究结果发表在国际学术期刊NatureMedicine上。研究人员发现在治疗中阻断c-Fos和Dusp1这两个蛋白能够治愈一些受激酶驱动且抵抗治疗的白血病和实体瘤。 | Meenu Kesarwani, Zachary Kincaid, Ahmed Gomaa, Erika Huber, Sara Rohrabaugh, Zain Siddiqui, Muhammad F Bouso, Kakajan Komurov, James C Mulloy, Jose A Cancelas, H Leighton Grimes Mohammad Azam Tahir Latif Ming Xu H Leighton Grimes Mohammad Azam | 2017 | 现代生物医学进展2017，17，17： | 4 |
| 2 | Bioavailability enhancers of herbal origin:An overview显示文摘Recently,the use of herbal medicines has been increased all over the world due to their therapeutic effects and fewer adverse effects as compared to the modern medicines.However,many herbal drugs and herbal extracts despite of their impressive in-vitro findings demonstrates less or negligible in-vivo activity due to their poor lipid solubility or improper molecular size,resulting in poor absorption and hence poor bioavailability.Nowadays with the advancement in the technology,novel drug delivery systems open the door towards the development of enhancing bioavailability of herbal drug delivery systems.For last one decade many novel carriers such as liposomes,microspheres,nanoparticles,transferosomes,ethosomes,lipid based systems etc.have been reported for successful modified delivery of various herbal drugs.Many herbal compounds including quercetin,genistein,naringin,sinomenine,pipeline,glycvrrhizin and nitrile glycoside have demonstrated capability to enhance the bioavailability.The objective of this review is to summarize various available novel drug delivery technologies which have been developed for delivery of drugs(herbal),and to achieve better therapeutic response.An attempt has also been made to compile a profile on bioavailability enhancers of herbal origin with the mechanism of action(wherever reported)and studies on improvement in drug bioavailability,exhibited particularly by natural compounds. | Kritika Kesarwani Rajiv Gupta | 2013 | Asian Pacific Journal of Tropical Biomedicine2013，3，4： | 3 |
| 3 | Role of Tumor Necrosis Factor-Alpha (C-863A) Polymorphism in Pathogenesis of Inflammatory Bowel Disease in Northern India显示文摘 | Dinesh Ahirwar Pravin Kesarwani Ranjana Singh Uday Ghoshal Rama Mittal | 2012 | Journal of Gastrointestinal Cancer2012，，2： | 3 |
| 4 | Oxalate decarboxylase from Collybia velutipes molecular cloning and its overexpression to confer resistance to fungal infection in transgenic tobacco and tomato显示文摘 | Kesarwani M Azam M Natarajan K | 2000 | Journal of Biological Chemistry2000，275，： | 1 |
| 5 | Upper pole access for complex lower pole renal calculi显示文摘 | Aron M Goel R Kesarwani P K | 2004 | BJU Int2004，94，16： | 1 |
| 6 | Upper pole access for complex lower pole renal calculi 显示文摘 | Aron M Goel R Kesarwani PK | 2004 | BJU International2004，94，6： | 1 |
| 7 | Percutaneous antegrade removal of impacted upper-ureteral calculi:still the treatment of choice in developing countries显示文摘 | GOEL R ARON M KESARWANI PK | 2005 | J Endourol2005，19，1： | 1 |
| 8 | Percutaneous antegrade removal of impacted upper areteral calculi: still the treatment of choice indeveloping countries显示文摘 | GOEL R ARON M KESARWANI PK | 2005 | J Endoarol2005，19，1： | 1 |
| 9 | Percutaneous antegrade removal of impacted upper ureteral calculi: still the treatment of choice in developing countries显示文摘 | Goel R Aron M Kesarwani P K | 2005 | J Endourol2005，19，1： | 1 |
| 10 | Big mother or small baby: which predicts hypertension 显示文摘 | Filler G Yasin A Kesarwani P | 2011 | J Clin Hypertens (Greenwich)2011，13，： | 1 |
| 11 | Genetic interactions of TGA transcription factors in the regulation ofpathogene- sis-related genes and disease resistance in Arabidopsis 显示文摘 | KESARWANI M YOO J DONG X | 2007 | Plant Physiol2007，144，1： | 1 |
| 12 | Percutaneous antegrade removal of impacted upper-ureteral calculi: still the treatment of choice in developing countries显示文摘 | Goel R Aron M Kesarwani P K etal | 2005 | J Endourol2005，19，： | 1 |
| 13 | Improved Variational Solution of the 3:homas-Fermi Equalion for Atoms 显示文摘 | KESARWANI R N '/~ARSHNI Y P | 1981 | PhyRev A1981，23，3： | 1 |
| 14 | Pereutaneous an - tegrade re - moval of impacted upper ureteral calculi : still the treatment of choiceindeveloping countries 显示文摘 | Goel R Aron M Kesarwani P K | 2005 | J Endourol2005，19，1： | 1 |
| 15 | Percutaneous antegrade removal of impacted upper-ureteral calculi:still the treatment of choice in developing countries显示文摘 | GOEL R ARON M KESARWANI P K | 2006 | J Endourol2006，20，7： | 1 |
| 16 | Percutaneous antegrade removal of impacted upper-ureteral calculi:still the treatment of choice in developing countries显示文摘 | Goet R Aron M Kesarwani PK | | 0，，14： | 1 |
| 17 | Percutaneous antegrade removal of impacted upper-ureteral calculi:still the treatment of choice in developing countries显示文摘 | GOEL R ARON M KESARWANI P K | 2005 | J Endourol2005，19，： | 1 |
| 18 | Induction of protein secretory pathway is required for systemic acquired resistance 显示文摘 | Wang D Weaver N D Kesarwani M | 2005 | Science2005，308，5724： | 1 |
| 19 | Percutaneous antegrade removal of impacted upper-ureteral calculi : still the treatment of choice in de-veloping countries显示文摘 | Goel R Aron M Kesarwani PK | 2005 | J Endourol2005，19，1： | 1 |
| 20 | Percutaneous antegrade removal of impacted upper-ureteral calculi:still the treatment of choice in developing countries显示文摘 | GOEL R ARON M KESARWANI P K | | 0，，01： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员